Justifying angiotensin blockers in essential hypertension Newsletter Article 15 February 2013 Pages: 2 - 2
Is granisetron the ‘preferred’ antiemetic? Robert Short Newsletter Article 15 February 2013 Pages: 3 - 4
H. pylori eradication - important health impact expected Newsletter Article 15 February 2013 Pages: 4 - 4
Promises of cost savings with piperacillin/tazobactam Newsletter Article 15 February 2013 Pages: 6 - 6
Hirudin - a new alternative for PTCA in patients with stable angina Newsletter Article 15 February 2013 Pages: 8 - 8
Do antibacterials come with resistance ‘prepacked’? Newsletter Article 15 February 2013 Pages: 10 - 10
Encouraging results with flesinoxan in refractory depression Newsletter Article 15 February 2013 Pages: 10 - 10
Phase I trials bode well for future treatment of cancer Newsletter Article 15 February 2013 Pages: 10 - 10
Exposure therapy vs fluvoxamine - long term outcome in OCD Newsletter Article 15 February 2013 Pages: 11 - 11
Intensive therapy improves ALL outcome - CCG-106 Study Newsletter Article 15 February 2013 Pages: 12 - 12
Opinions on the best way to keep the sheets dry Sean Henahan Newsletter Article 15 February 2013 Pages: 13 - 13
Rufloxacin once-daily similar to amoxicillin tid in bronchitis Newsletter Article 15 February 2013 Pages: 14 - 14
Enoxaparin sodium on a par with heparin for DVT after vascular surgery Newsletter Article 15 February 2013 Pages: 15 - 15
Triple immunosuppression superior in children with heart transplants Newsletter Article 15 February 2013 Pages: 16 - 16
Interferon-α2B doesn’t influence survival in NSCLC Newsletter Article 15 February 2013 Pages: 16 - 16
For soft tissue injuries - ultrasound and felbinac are similar Newsletter Article 15 February 2013 Pages: 16 - 16
Postmenopausal HRT and cardiovascular disease risk Newsletter Article 15 February 2013 Pages: 16 - 16
Transdermal estradiol - risks small compared with benefits Newsletter Article 15 February 2013 Pages: 17 - 17